Added to YB: 2016-02-19
Pitch date: 2016-02-19
CNCE:US [bullish]
Concert Pharmaceuticals, Inc.
-67.67%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Concert Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that develops novel small-molecule drugs for the treatment of autoimmune diseases.
Market Cap
$520.7M
Pitch Price
$25.89
Price Target
N/A
Dividend
N/A
EV/EBITDA
-4.35
P/E
-2.69
EV/Sales
12.03
Sector
Biotechnology
Category
N/A
Show full summary:
CONCERT PHARMACEUTICALS INC COM CNCE:US
A summary for this pitch has not been created yet.
Read full article (0 min)